Market Leads & Opportunities
United Kingdom-Edinburgh: Pharmaceutical products – Framework Lead
The current contract for Pharmaceutical products – Framework Lead is projected to end on 24-FEB-20 and may be available for retender. Erythropoietin Stimulating Agents and Sevelamer.
Erythropoietin Stimulating Agents and Sevelamer.
This Framework Agreement is for the supply of a range of Erythropoietin Stimulating Agents and Sevelamer to Health Boards across NHS Scotland and the provision of a Home Delivery Service for the delivery of Erythropoietin Stimulating Agents Medicines to patient homes across NHS Scotland.
The framework agreement will be awarded as a single supplier framework on a line by line basis for each product line.
Additional information is available in the tender documentation.
This Framework Agreement is for the supply of a range of Erythropoietin Stimulating Agents and Sevelamer to Health Boards across NHS Scotland and the provision of a Home Delivery Service for the delivery of Erythropoietin Stimulating Agents Medicines to patient homes across NHS Scotland.
The framework agreement will be awarded as a single supplier framework on a line by line basis for each product line.
Additional information is available in the tender documentation.
Common procurement vocabulary (CPV): 33600000, Pharmaceutical products, 33696100, Blood-grouping reagents,
More Market Leads
- Committee to decide on more than 100 homes in Somerset
26 Feb 25
Plans for more than 100 homes in Somerset will go before committee today (25 February). - Funding for Argyll and Bute housing projects
26 Feb 25
The UK Government has committed to delivering a package of support from the CRP to Argyll and Bute Council totalling £20.34 million. - Lead developer sought for city centre redevelopment
26 Feb 25
Hull City Council says it has taken a step forward on its redevelopment of the former BHS building in the city centre.
